Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Comprehensive Genome Analysis of Carbapenemase-Producing Enterobacter spp.: New Insights into Phylogeny, Population Structure, and Resistance Mechanisms.

Chavda KD, Chen L, Fouts DE, Sutton G, Brinkac L, Jenkins SG, Bonomo RA, Adams MD, Kreiswirth BN.

MBio. 2016 Dec 13;7(6). pii: e02093-16. doi: 10.1128/mBio.02093-16.

2.

KlebSeq, a Diagnostic Tool for Surveillance, Detection, and Monitoring of Klebsiella pneumoniae.

Bowers JR, Lemmer D, Sahl JW, Pearson T, Driebe EM, Wojack B, Saubolle MA, Engelthaler DM, Keim P.

J Clin Microbiol. 2016 Oct;54(10):2582-96. doi: 10.1128/JCM.00927-16.

3.

Nested Russian Doll-Like Genetic Mobility Drives Rapid Dissemination of the Carbapenem Resistance Gene blaKPC.

Sheppard AE, Stoesser N, Wilson DJ, Sebra R, Kasarskis A, Anson LW, Giess A, Pankhurst LJ, Vaughan A, Grim CJ, Cox HL, Yeh AJ; Modernising Medical Microbiology (MMM) Informatics Group., Sifri CD, Walker AS, Peto TE, Crook DW, Mathers AJ.

Antimicrob Agents Chemother. 2016 May 23;60(6):3767-78. doi: 10.1128/AAC.00464-16.

4.

Carbapenem resistance: overview of the problem and future perspectives.

Meletis G.

Ther Adv Infect Dis. 2016 Feb;3(1):15-21. doi: 10.1177/2049936115621709. Review.

5.

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections.

Morrill HJ, Pogue JM, Kaye KS, LaPlante KL.

Open Forum Infect Dis. 2015 May 5;2(2):ofv050. doi: 10.1093/ofid/ofv050. Review.

6.

Population Structure of Klebsiella pneumoniae Causing Bloodstream Infections at a New York City Tertiary Care Hospital: Diversification of Multidrug-Resistant Isolates.

Gomez-Simmonds A, Greenman M, Sullivan SB, Tanner JP, Sowash MG, Whittier S, Uhlemann AC.

J Clin Microbiol. 2015 Jul;53(7):2060-7. doi: 10.1128/JCM.03455-14.

7.

New Delhi metallo-β-lactamase-producing Enterobacteriaceae, United States.

Rasheed JK, Kitchel B, Zhu W, Anderson KF, Clark NC, Ferraro MJ, Savard P, Humphries RM, Kallen AJ, Limbago BM.

Emerg Infect Dis. 2013 Jun;19(6):870-8. doi: 10.3201/eid1906.121515.

8.

"Stormy waters ahead": global emergence of carbapenemases.

Patel G, Bonomo RA.

Front Microbiol. 2013 Mar 14;4:48. doi: 10.3389/fmicb.2013.00048.

9.

Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998-2010.

Sanchez GV, Master RN, Clark RB, Fyyaz M, Duvvuri P, Ekta G, Bordon J.

Emerg Infect Dis. 2013 Jan;19(1):133-6. doi: 10.3201/eid1901.120310.

10.

IMP-producing carbapenem-resistant Klebsiella pneumoniae in the United States.

Limbago BM, Rasheed JK, Anderson KF, Zhu W, Kitchel B, Watz N, Munro S, Gans H, Banaei N, Kallen AJ.

J Clin Microbiol. 2011 Dec;49(12):4239-45. doi: 10.1128/JCM.05297-11.

11.

Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007.

Lee K, Lee MA, Lee CH, Lee J, Roh KH, Kim S, Kim JJ, Koh E, Yong D, Chong Y; KONSAR Group..

Yonsei Med J. 2010 Nov;51(6):901-11. doi: 10.3349/ymj.2010.51.6.901.

Supplemental Content

Support Center